Mina Levy
Impact in
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Amino Acid Enzymes and Metabolism 5
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Harry Eagle (14 shared papers)Ralph Fleischman (4 shared papers)Vance I. Oyama (5 shared papers)Aaron E. Freeman (3 shared papers)Henry O. Schulze (1 shared paper)Stanley Barban (1 shared paper)Karl A. Piez (1 shared paper)Andrew Freeman (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)Science (2 papers)Journal of Bacteriology (2 papers)Experimental Biology and Medicine (1 paper)Archives of Biochemistry and Biophysics (1 paper)
- Partner nations
- United States
In The Last Decade
Mina Levy
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Biochemistry 281
- Cancer Research 186
- Pharmacology 178
- Applied Microbiology and Biotechnology 22
- Molecular Biology 502
Countries citing papers authored by Mina Levy
This map shows the geographic impact of Mina Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Levy more than expected).
Fields of papers citing papers by Mina Levy
This network shows the impact of papers produced by Mina Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Levy. The network helps show where Mina Levy may publish in the future.
Co-authors
The 11 scholars most cited alongside Mina Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1956 | 301 | |
| 2 | 1957 | 243 | |
| 3 | 1953 | 197 | |
| 4 | 1958 | 190 | |
| 5 | 1961 | 103 | |
| 6 | 1957 | 40 | |
| 7 | 1965 | 40 | |
| 8 | 1966 | 39 | |
| 9 | 1958 | 33 | |
| 10 | 1952 | 32 | |
| 11 | On the duration of penicillin action in relation to its concentration in the serum. | 1953 | 21 |
| 12 | 1956 | 15 | |
| 13 | 1955 | 11 | |
| 14 | 1953 | 6 | |
| 15 | 1956 | 5 | |
| 16 | 1951 | 1 |
About Mina Levy
Mina Levy is a scholar working on Biochemistry, Pharmacology, Applied Microbiology and Biotechnology, Cancer Research and Molecular Biology, having authored 16 papers that have together received 1.3k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), RNA and protein synthesis mechanisms (3 papers), Streptococcal Infections and Treatments (2 papers) and Historical Medical Research and Treatments (2 papers). The work is most often cited by research in Biochemistry (281 citations), Cancer Research (186 citations), Pharmacology (178 citations), Applied Microbiology and Biotechnology (22 citations) and Molecular Biology (502 citations). Mina Levy has collaborated with scholars based in United States. Frequent co-authors include Harry Eagle, Ralph Fleischman, Vance I. Oyama, Aaron E. Freeman, Henry O. Schulze, Stanley Barban, Karl A. Piez, Andrew Freeman, Leonard A. Cohen and Robert W. Fleischman. Their work appears in journals such as Journal of Biological Chemistry, Science, Journal of Bacteriology, Experimental Biology and Medicine and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.